India medical device regulations

Class A non-sterile and non-measuring devices have a separate online registration framework under Rules19G-19M and the stated Eighth Schedule exemptions. The licensed major/minor PAC and constitution-clock answers must therefore not be applied to that subset without checking the registration route and its actual recorded information.

For already approved Class C/D IVDs, CDSCO FAQ Addendum02 Q24 directs a separate online application for endorsement of a brand or additional brand and CLA approval. Q19 says a name-only change of the actual manufacturing site without a constitution change uses PAC approval rather than a fresh licence. Q24 does not establish the identical operational route for every Class A/B IVD or for a new legal manufacturer.

The official Import License(Form MD-14) PAC label table marks the old/new label comparison with reasons, revised label and PAC application as mandatory. It marks an existing licence/retention with cover letter, foreign approval and packaging-validation evidence as No or conditional as printed. This is the listed import-PAC branch, not a dedicated subsequent-importer checklist.

For an IVD under the licensed regime, prior approval is required for a listed major change: the manufacture rule specifies45 days and the import rule60 days for approval/rejection, each with the printed deemed-approval-on-silence provision. Listed minor changes are notified within 30 days after the change. The rules do not convert dossier preparation or applicant response time into part of that authority clock.

For an IVD under the Medical Devices Rules, the label must identify the device, manufacturer and actual manufacturing premises and carry the applicable particulars in Rule 44. For imported products, specified missing importer name/address, import-licence number, manufacturing-premises address and manufacturing date may be added by stickering under Rule 44(n). That limited provision is not a blanket permission to relabel old stock after any transfer.

The substituted Rule 46 requires the unique device identification from the date and in the manner specified by a Central Government order. The substituted provision itself does not establish a calendar commencement date. A commercial REF or catalogue renumbering must first be mapped to the actual recorded product/label field; it is not automatically a UDI change.

Class A non-sterile and non-measuring devices have a separate online registration framework under Rules19G-19M and the stated Eighth Schedule exemptions. The licensed major/minor PAC and constitution-clock answers must therefore not be applied to that subset without checking the registration route and its actual recorded information.

For a licensed product, Sixth Schedule A6 lists a change in the name or address of the overseas manufacturer or its manufacturing site, domestic manufacturer or its site, and Indian authorised agent as a major change. A same-entity office-address or company-name change is assessed through this change procedure; it is not automatically a factory relocation or a change in constitution.

For already approved Class C/D IVDs, CDSCO FAQ Addendum02 Q24 directs a separate online application for endorsement of a brand or additional brand and CLA approval. Q19 says a name-only change of the actual manufacturing site without a constitution change uses PAC approval rather than a fresh licence. Q24 does not establish the identical operational route for every Class A/B IVD or for a new legal manufacturer.

The official Import License(Form MD-14) PAC label table marks the old/new label comparison with reasons, revised label and PAC application as mandatory. It marks an existing licence/retention with cover letter, foreign approval and packaging-validation evidence as No or conditional as printed. This is the listed import-PAC branch, not a dedicated subsequent-importer checklist.

The import PAC table for overseas manufacturer or manufacturing-site name without a constitution change requires the PAC application and reason, existing licence/retention documentation, authenticated power of attorney with agent undertaking, origin site/establishment registration and quality certificates showing the name change. Its FSC row is marked No; several label/PMF/undertaking rows are also marked No. Do not replace those flags with a universal all-certificates-first requirement.

For an IVD under the licensed regime, prior approval is required for a listed major change: the manufacture rule specifies45 days and the import rule60 days for approval/rejection, each with the printed deemed-approval-on-silence provision. Listed minor changes are notified within 30 days after the change. The rules do not convert dossier preparation or applicant response time into part of that authority clock.

For an IVD under the Medical Devices Rules, the label must identify the device, manufacturer and actual manufacturing premises and carry the applicable particulars in Rule 44. For imported products, specified missing importer name/address, import-licence number, manufacturing-premises address and manufacturing date may be added by stickering under Rule 44(n). That limited provision is not a blanket permission to relabel old stock after any transfer.

The substituted Rule 46 requires the unique device identification from the date and in the manner specified by a Central Government order. The substituted provision itself does not establish a calendar commencement date. A commercial REF or catalogue renumbering must first be mapped to the actual recorded product/label field; it is not automatically a UDI change.

Class A non-sterile and non-measuring devices have a separate online registration framework under Rules19G-19M and the stated Eighth Schedule exemptions. The licensed major/minor PAC and constitution-clock answers must therefore not be applied to that subset without checking the registration route and its actual recorded information.

For a licensed product, Sixth Schedule A6 lists a change in the name or address of the overseas manufacturer or its manufacturing site, domestic manufacturer or its site, and Indian authorised agent as a major change. A same-entity office-address or company-name change is assessed through this change procedure; it is not automatically a factory relocation or a change in constitution.

For already approved Class C/D IVDs, CDSCO FAQ Addendum02 Q24 directs a separate online application for endorsement of a brand or additional brand and CLA approval. Q19 says a name-only change of the actual manufacturing site without a constitution change uses PAC approval rather than a fresh licence. Q24 does not establish the identical operational route for every Class A/B IVD or for a new legal manufacturer.

The official Import License(Form MD-14) PAC label table marks the old/new label comparison with reasons, revised label and PAC application as mandatory. It marks an existing licence/retention with cover letter, foreign approval and packaging-validation evidence as No or conditional as printed. This is the listed import-PAC branch, not a dedicated subsequent-importer checklist.

The import PAC table for overseas manufacturer or manufacturing-site name without a constitution change requires the PAC application and reason, existing licence/retention documentation, authenticated power of attorney with agent undertaking, origin site/establishment registration and quality certificates showing the name change. Its FSC row is marked No; several label/PMF/undertaking rows are also marked No. Do not replace those flags with a universal all-certificates-first requirement.

For an overseas legal-manufacturer address change without constitution change, the import-PAC table requires the application/reason, authenticated power of attorney and agent undertaking, manufacturer no-constitution-change undertaking, notarised origin site/establishment registration, a notarised reference-country FSC and quality-certificate evidence. This office branch is distinct from physically relocating a manufacturing site.

For an IVD under the licensed regime, prior approval is required for a listed major change: the manufacture rule specifies45 days and the import rule60 days for approval/rejection, each with the printed deemed-approval-on-silence provision. Listed minor changes are notified within 30 days after the change. The rules do not convert dossier preparation or applicant response time into part of that authority clock.

For an IVD under the Medical Devices Rules, the label must identify the device, manufacturer and actual manufacturing premises and carry the applicable particulars in Rule 44. For imported products, specified missing importer name/address, import-licence number, manufacturing-premises address and manufacturing date may be added by stickering under Rule 44(n). That limited provision is not a blanket permission to relabel old stock after any transfer.

The substituted Rule 46 requires the unique device identification from the date and in the manner specified by a Central Government order. The substituted provision itself does not establish a calendar commencement date. A commercial REF or catalogue renumbering must first be mapped to the actual recorded product/label field; it is not automatically a UDI change.

Class A non-sterile and non-measuring devices have a separate online registration framework under Rules19G-19M and the stated Eighth Schedule exemptions. The licensed major/minor PAC and constitution-clock answers must therefore not be applied to that subset without checking the registration route and its actual recorded information.

The import-PAC model-number table requires proposed details, old/new comparison with justification, existing licence/retention, predicate or similar-device reference, relevant DMF and Essential Principles changes, risk report, proposed label, applicable test reports, three-batch release/analysis evidence and notarised FSC/quality certificates. Use this table only if the changed order code is actually the registered model field.

The substituted Rule 46 requires the unique device identification from the date and in the manner specified by a Central Government order. The substituted provision itself does not establish a calendar commencement date. A commercial REF or catalogue renumbering must first be mapped to the actual recorded product/label field; it is not automatically a UDI change.

For already approved Class C/D IVDs, CDSCO FAQ Addendum02 Q24 directs a separate online application for endorsement of a brand or additional brand and CLA approval. Q19 says a name-only change of the actual manufacturing site without a constitution change uses PAC approval rather than a fresh licence. Q24 does not establish the identical operational route for every Class A/B IVD or for a new legal manufacturer.

The official Import License(Form MD-14) PAC label table marks the old/new label comparison with reasons, revised label and PAC application as mandatory. It marks an existing licence/retention with cover letter, foreign approval and packaging-validation evidence as No or conditional as printed. This is the listed import-PAC branch, not a dedicated subsequent-importer checklist.

For an IVD under the licensed regime, prior approval is required for a listed major change: the manufacture rule specifies45 days and the import rule60 days for approval/rejection, each with the printed deemed-approval-on-silence provision. Listed minor changes are notified within 30 days after the change. The rules do not convert dossier preparation or applicant response time into part of that authority clock.

For an IVD under the Medical Devices Rules, the label must identify the device, manufacturer and actual manufacturing premises and carry the applicable particulars in Rule 44. For imported products, specified missing importer name/address, import-licence number, manufacturing-premises address and manufacturing date may be added by stickering under Rule 44(n). That limited provision is not a blanket permission to relabel old stock after any transfer.

Class A non-sterile and non-measuring devices have a separate online registration framework under Rules19G-19M and the stated Eighth Schedule exemptions. The licensed major/minor PAC and constitution-clock answers must therefore not be applied to that subset without checking the registration route and its actual recorded information.

For an import licence, a qualifying change in the constitution of the authorised agent or overseas manufacturer that executed the power of attorney requires written notice within 30 days and a fresh licence application within 180 days. Rule 39 preserves the existing licence pending issue or rejection of the fresh licence. Manufacture uses Rule27 with45-day notice and180-day application. This licence continuity does not itself authorise continued use of an inaccurate old label.

IVD FAQ Addendum02 Q7 directs a new authorised agent to the Subsequent Importer portal application only for an already licensed IVD where the legal and actual manufacturing site remain the same. It does not grant a transfer to a different foreign manufacturer or establish the contents of the separately referenced final subsequent-importer checklist.

For already approved Class C/D IVDs, CDSCO FAQ Addendum02 Q24 directs a separate online application for endorsement of a brand or additional brand and CLA approval. Q19 says a name-only change of the actual manufacturing site without a constitution change uses PAC approval rather than a fresh licence. Q24 does not establish the identical operational route for every Class A/B IVD or for a new legal manufacturer.

The official Import License(Form MD-14) PAC label table marks the old/new label comparison with reasons, revised label and PAC application as mandatory. It marks an existing licence/retention with cover letter, foreign approval and packaging-validation evidence as No or conditional as printed. This is the listed import-PAC branch, not a dedicated subsequent-importer checklist.

For an IVD under the licensed regime, prior approval is required for a listed major change: the manufacture rule specifies45 days and the import rule60 days for approval/rejection, each with the printed deemed-approval-on-silence provision. Listed minor changes are notified within 30 days after the change. The rules do not convert dossier preparation or applicant response time into part of that authority clock.

For an IVD under the Medical Devices Rules, the label must identify the device, manufacturer and actual manufacturing premises and carry the applicable particulars in Rule 44. For imported products, specified missing importer name/address, import-licence number, manufacturing-premises address and manufacturing date may be added by stickering under Rule 44(n). That limited provision is not a blanket permission to relabel old stock after any transfer.

The substituted Rule 46 requires the unique device identification from the date and in the manner specified by a Central Government order. The substituted provision itself does not establish a calendar commencement date. A commercial REF or catalogue renumbering must first be mapped to the actual recorded product/label field; it is not automatically a UDI change.

Class A non-sterile and non-measuring devices have a separate online registration framework under Rules19G-19M and the stated Eighth Schedule exemptions. The licensed major/minor PAC and constitution-clock answers must therefore not be applied to that subset without checking the registration route and its actual recorded information.

For a licensed product, Sixth Schedule A6 lists a change in the name or address of the overseas manufacturer or its manufacturing site, domestic manufacturer or its site, and Indian authorised agent as a major change. A same-entity office-address or company-name change is assessed through this change procedure; it is not automatically a factory relocation or a change in constitution.

The import-PAC model-number table requires proposed details, old/new comparison with justification, existing licence/retention, predicate or similar-device reference, relevant DMF and Essential Principles changes, risk report, proposed label, applicable test reports, three-batch release/analysis evidence and notarised FSC/quality certificates. Use this table only if the changed order code is actually the registered model field.

The substituted Rule 46 requires the unique device identification from the date and in the manner specified by a Central Government order. The substituted provision itself does not establish a calendar commencement date. A commercial REF or catalogue renumbering must first be mapped to the actual recorded product/label field; it is not automatically a UDI change.

For an import licence, a qualifying change in the constitution of the authorised agent or overseas manufacturer that executed the power of attorney requires written notice within 30 days and a fresh licence application within 180 days. Rule 39 preserves the existing licence pending issue or rejection of the fresh licence. Manufacture uses Rule27 with45-day notice and180-day application. This licence continuity does not itself authorise continued use of an inaccurate old label.

IVD FAQ Addendum02 Q7 directs a new authorised agent to the Subsequent Importer portal application only for an already licensed IVD where the legal and actual manufacturing site remain the same. It does not grant a transfer to a different foreign manufacturer or establish the contents of the separately referenced final subsequent-importer checklist.

For already approved Class C/D IVDs, CDSCO FAQ Addendum02 Q24 directs a separate online application for endorsement of a brand or additional brand and CLA approval. Q19 says a name-only change of the actual manufacturing site without a constitution change uses PAC approval rather than a fresh licence. Q24 does not establish the identical operational route for every Class A/B IVD or for a new legal manufacturer.

The official Import License(Form MD-14) PAC label table marks the old/new label comparison with reasons, revised label and PAC application as mandatory. It marks an existing licence/retention with cover letter, foreign approval and packaging-validation evidence as No or conditional as printed. This is the listed import-PAC branch, not a dedicated subsequent-importer checklist.

The import PAC table for overseas manufacturer or manufacturing-site name without a constitution change requires the PAC application and reason, existing licence/retention documentation, authenticated power of attorney with agent undertaking, origin site/establishment registration and quality certificates showing the name change. Its FSC row is marked No; several label/PMF/undertaking rows are also marked No. Do not replace those flags with a universal all-certificates-first requirement.

For an overseas legal-manufacturer address change without constitution change, the import-PAC table requires the application/reason, authenticated power of attorney and agent undertaking, manufacturer no-constitution-change undertaking, notarised origin site/establishment registration, a notarised reference-country FSC and quality-certificate evidence. This office branch is distinct from physically relocating a manufacturing site.

For an IVD under the licensed regime, prior approval is required for a listed major change: the manufacture rule specifies45 days and the import rule60 days for approval/rejection, each with the printed deemed-approval-on-silence provision. Listed minor changes are notified within 30 days after the change. The rules do not convert dossier preparation or applicant response time into part of that authority clock.

For an IVD under the Medical Devices Rules, the label must identify the device, manufacturer and actual manufacturing premises and carry the applicable particulars in Rule 44. For imported products, specified missing importer name/address, import-licence number, manufacturing-premises address and manufacturing date may be added by stickering under Rule 44(n). That limited provision is not a blanket permission to relabel old stock after any transfer.